More
    Guided Solutions - Connecting Talent With Innovation/div>

    FDA approves MediBeacon’s TGFR system for kidney function assessment

    The US Food and Drug Administration (FDA) has granted approval to the MediBeacon Transdermal GFR (TGFR) system for evaluating kidney function in individuals with...

    FDA grants IDE approval for NextBioMedical’s Nexsphere-F trial

    The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for NextBioMedical’s randomised trial involving its fast-resorbable embolic microsphere, Nexsphere-F,...

    SurGenTec receives FDA clearance for synthetic bone graft material

    SurGenTec has gained 510(k) clearance for OsteoFlo HydroFiber, a synthetic material for use in spinal surgery, from the US Food and Drug Administration (FDA). For...

    CergenX wins FDA breakthrough nod for neonatal brain monitoring tech

    CergenX announced the FDA granted breakthrough device designation for its Wave device for neonatal brain monitoring. Additionally, the FDA accepted the Cork, Ireland-based company...

    FDA grants clearance to icotec’s BlackArmor implants to treat spinal infection

    The US Food and Drug Administration (FDA) has granted clearance to icotec for the use of its BlackArmor implants in treating de novo spinal...

    Q’Apel Medical wins CE mark for Armadillo neurovascular access system

    Q’Apel Medical received CE mark certification for its Armadillo SelectFlex Neurovascular Access System. The 7F system uses the company’s SelectFlex Technology and is indicated...

    Biobot Surgical wins CE mark for Mona Lisa surgical robot

    Biobot Surgical received CE mark for its Mona Lisa 2.0 surgical robotic platform for urology applications. Approval in Europe adds to existing approvals in...

    FDA clears CapsoVision capsule endoscopy tech for pediatric patients

    CapsoVision announced today that the FDA cleared its CapsoCam Plus system for use in pediatric patients aged two and above. The CapsoCam Plus system...

    neuroClues secures CE certification for its eye-tracking technology set to enhance neurologic care

    neuroClues, a European MedTech company specialising in the diagnosis of neurodegenerative diseases, received the MDR certificate for its groundbreaking eye-tracking device. Innovation in the EU...

    Latest articles